5-FU THERAPEUTIC MONITORING WITH DOSE ADJUSTMENT LEADS TO AN IMPROVED THERAPEUTIC INDEX IN HEAD AND NECK-CANCER

被引：174

作者：

SANTINI, J ^{[1
]}

MILANO, G ^{[1
]}

THYSS, A ^{[1
]}

RENEE, N ^{[1
]}

VIENS, P ^{[1
]}

AYELA, P ^{[1
]}

SCHNEIDER, M ^{[1
]}

DEMARD, F ^{[1
]}

机构：

[1] CTR ANTOINE LACASSAGNE,36 VOIE ROMAINE,F-06054 NICE,FRANCE

来源：

BRITISH JOURNAL OF CANCER | 1989年 / 59卷 / 02期

关键词：

D O I：

10.1038/bjc.1989.59

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：287 / 290

页数：4

共 17 条

[1] PHARMACOKINETIC PRINCIPLES OF ANTI-NEOPLASTIC DRUG-THERAPY [J].

ALLEN, LM .

JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 23 (2-3) :71-81

[2] TREATMENT OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CISPLATIN AND 5-FLUOROURACIL [J].

AMREIN, PC ;

WIETZMAN, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1632-1639

[3] A CONTROLLED EVALUATION OF RECENT APPROACHES TO BIOCHEMICAL MODULATION OR ENHANCEMENT OF 5-FLUOROURACIL THERAPY IN COLORECTAL-CARCINOMA [J].

BUROKER, TR ;

MOERTEL, G ;

FLEMING, TR ;

EVERSON, LK ;

CULLINAN, SA ;

KROOK, JE ;

MAILLIARD, JA ;

MARSCHKE, RF ;

KLAASSEN, DJ ;

LAURIE, JA ;

MOON, MD .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1624-1631

[4]

CHRISTOPHIDIS N, 1979, CLIN CHEM, V25, P83

[5]

KIES MS, 1987, CANCER, V60, P2156, DOI 10.1002/1097-0142(19871101)60:9<2156::AID-CNCR2820600906>3.0.CO

[6]

2-G

[7]

KISH J, 1982, CANCER TREAT REP, V66, P471

[8]

MERLANO M, 1987, CANCER TREAT REP, V71, P485

[9]

MYERS CE, 1981, PHARMACOL REV, V33, P1

[10]

POWIS G, 1985, CANCER CHEMOTH PHARM, V14, P177

← 1 2 →